The Global Tretinoin Market is anticipated to gain popularity over the coming years as tretinoin products are used to treat acute promyelocytic leukemia and acne. This information was announced by Fortune Business Insights in a report, titled “Tretinoin Market Size, Share and Global Trend By Application (Acne, Acute Promyelocytic Leukemia (APL)), By Strength (0.025%, 0.01%, 0.05%, 0.1%), By Distribution Channel (Hospitals & Clinics Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of administration (Topical Applications, Oral), Geography Forecast till 2026.” Tretinoin also referred to as Retin-A helps to treat skin discoloration and aging.
Some of the Main Key Players Covered in the Report
- Sun Pharma Advanced Research Company Ltd.
- Glaxosmithkline Inc.
- Janssen Inc.
- Bausch Health Companies Inc.
- Ortho Dermatologics
The report mentions that the demand for tretinoin products in hospitals, retail, and online pharmacies is likely to increase in the coming years. Furthermore, as per the report, acne treatment accounts for a major share in the global market at present and continues to remain strong in the forecast years. This is ascribable to the rising use of tretinoin for acne vulgaris as compared to acute promyelocytic leukemia.
Adverse Effects of Tretinoin Products May Hamper Growth
Certain factors that may inhibit the growth of the market include side effects of tretinoin products. These side effects such as itching, excessive dryness, redness, and scaling may restrict the market’s growth. Also, administration of tretinoin for the treatment of leukaemia can have some side effects such as retinoic acid syndrome, liver damage, hypertension and others. These side-effects may pose a serious threat to the market during the forecast duration.
- Acute Promyelocytic Leukemia (APL)
By Distribution Channel
- Hospitals & Clinics Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Route of administration
- Topical Applications
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Demand for Tretinoin Products is the Highest in North America and Europe
Among regions, North America and Europe are anticipated to hold a major share in the global tretinoin market throughout the forecast years. The rising prevalence of acne vulgaris in the U.S. is the main factor likely to drive the market in this region. Also, rising FDA approvals for the treatment of acne is expected to create growth opportunities for the market by 2026.
Well-established healthcare infrastructure is expected to encourage growth in the market in Europe by 2026. The market in the Asia Pacific is likely to register considerable growth during the forecast period. Japan is projected to offer the largest market opportunity owing to the presence of a drug manufacturer called Chugai. The manufacturing unit is controlled by F. Hoffmann-La Roche AG in Japan.
More Trending Topics from Future Business Insights: